Your Template Here
Create an HTML page using whatever layout and sizing you like. Link to your own stylesheets for consistency with your main website. Then place the word [ minisite ] where you want our MiniSite to appear. Our system automatically inserts the latest content and serves it to your readers.
Navigation
When your navigation changes, you can log into our admin panel and upload a new template. Or, just use an iframe to share code from your main website. We don't stand between you and your regular web updates.
In addition to your standard site navigation, MiniSites are a great place to link to existing revenue drivers. You can create any connections you like between different areas of your site. MiniSites can offer gateways to:
- Coupons
- Directories
- Mini-sites
- Storefronts
- And more!
 |
||||
Breast Cancer Breakthrough An iron-regulating protein could spare women from the fate of intense treatment 
Breast cancer patients may be able to avoid invasive and toxic treatments thanks to a new study, published in the online version of the journal, Science Translational Medicine. Researchers at Wake Forest University Baptist Medical Center (WFUBMC) found that low levels of ferroportin, the only known protein to eliminate iron from cells, are associated with the most aggressive and recurring cancers. The findings suggests that testing for ferroportin levels in women with breast cancer may one day help doctors to more accurately predict the likelihood of the cancer’s return, helping some women avoid treatments such as chemotherapy. “Ferroportin expression may help predict whether women who have had breast cancer will relapse or not,” says Frank M. Torti, M.D., director of the Comprehensive Cancer Center at WFUBMC, and senior author on the paper and co-lead investigator for the study. Torti added that the results suggest that levels of ferroportin may eventually help guide therapy for breast cancer patients. Drawing on the hypothesis that iron may be altered in breast cancer and that the alteration might be important in the behavior of the cancer, researchers first found a significant reduction of ferroportin in cancerous cells compared to that of normal breast cells. After artificially restoring ferroportin to near normal levels in an aggressive breast cancer cell line, they noticed that these cells grew more slowly than the tumors formed by cells with depleted levels of protein. According to Suzy V. Torti, Ph.D., an associate professor of biochemistry at Wake Forest Baptist and co-lead investigator on the paper, the reason for these findings is simple. "In the case of cancer, the ability to remove iron from cells is reduced by the depleted ferroportin levels, and as a result, iron accumulates in cancer cells. Cancer cells require iron, which allows the tumor to grow faster and perhaps become more aggressive. Because ferroportin can remove iron from the cell, when we put the protein back into the cell, the ferroportin removed the cancer's growth stimulus. Our findings suggest that ferroportin is a substantial influence on the behavior of the cancer," she says. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), of the National Institutes of Health (NIH), funded the study. |
||||
|
||||
Advertisements
You can use the space around the MiniSite content to create multiple ad and sponsorship positions that you can customize to your market. In fact, you can create a premium sponsorship opportunity by inserting ads or custom navigation inside the MiniSite area using a special feature in our system.
If you use JavaScript tags for ad serving or site tracking, you can add them to your template, and manage your MiniSite pages with the same tools you use to manage the rest of your site.
Footer